Hypertrophic cardiomyopathy: Management issues in the new millennium

被引：4
作者：
Thaman R. [1 ]
Firoozi S. [1 ]
Hamid M.S. [1 ]
Mckenna W.J. [1 ]
机构：
[1] Department of Cardiological Sciences, St. George's Hospital Medical School, Cranmer Terrace
来源：
Current Cardiology Reports | 2002年 / 4卷 / 3期
关键词：
Right Ventricular; Amiodarone; Sudden Death; Left Ventricular Hypertrophy; Sudden Cardiac Death;
D O I：
10.1007/s11886-002-0055-z
中图分类号：
学科分类号：
摘要：
Hypertrophic cardiomyopathy is an inherited cardiac disorder. Sudden cardiac death frequently occurs in otherwise healthy individuals, and accounts for nearly 35% of all sudden deaths within this age group. Although symptoms occur commonly, they often go unreported. Despite this, a degree of functional limitation is often seen on objective assessment. Management of hypertrophic cardiomyopathy is aimed at relieving symptoms, identifying and treating those individuals at increased risk of sudden death, and screening family members. © 2002 by Current Science Inc.
引用
收藏
页码：226 / 232
页数：6
相关论文
共 45 条
[1]  
Maron B.J., Gardin J.M., Flack J.M., Et al., Prevalence of hypertrophic cardiomyopathy in a general population of young adults
[2]  
echocardiographic analysis of 4111 subjects in the cardia study, Circulation, 92, pp. 785-789, (1995)
[3]  
McKenna W.J., Deanfield J., Faruqui A., Et al., Prognosis in hypertrophic cardiomyopathy. Role of age and clinical, electrocardiographic and haemodynamic features, Am J Cardiol, 47, pp. 532-538, (1981)
[4]  
Maron B.J., Wolfson J.K., Epstein S.E., Roberts W.C., Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy, J Am Coll Cardiol, 8, (1986)
[5]  
Kimura A., Harada H., Park J.-E., Et al., Mutations in the cardiac troponin i gene associated with hypertrophic cardiomyopathy, Nat Genet, 16, pp. 379-382, (1997)
[6]  
Jarcho J.A., McKenna W.J., Pare J.A., Et al., Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1, N Engl J Med, 321, pp. 1372-1378, (1989)
[7]  
Thierfelder L., MacRae C., Watkins H., Et al., A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2, Proc Natl Acad Sci U S A, 90, pp. 6270-6274, (1993)
[8]  
Watkins H., McRae C., Thierfelder L., Et al., A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3, Nat Genet, 3, pp. 333-337, (1993)
[9]  
Bonne G., Carrier L., Bercovici J., Et al., Cardiac myosin binding protein c gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy, Nat Genet, 11, pp. 438-440, (1995)
[10]  
Watkins H., Rozenzweig A., Hwang D.S., Et al., Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy, N Engl J Med, 326, pp. 1108-1114, (1992)
12345